From early warning signs to prevention tips, here’s all that you need to know about this rare hormonal disorder.

A light period can be caused by stress hormonal imbalances or medical conditions It’s important to monitor your cycle and ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

CORT's Cushing's syndrome drug, Korlym, is driving revenues. The FDA's acceptance of the NDA for relacorilant also bodes well ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for relacorilant to treat patients with Cushing syndrome (hypercortisolism).

Corcept Therapeutics (CORT) announced the initiation of MOMENTUM, a clinical trial examining the prevalence of endogenous ...

Corcept's new drug, relacorilant, shows promise with positive Phase 3 results and an FDA decision expected. Learn more about ...

Ginny Hooper, who has been battling a rare cancer and Cushing syndrome over the last year, is working to normalize the conversation around it. Thanks to the help of the Make-A-Wish foundation, Hooper ...

Australians suffering from the debilitating condition Cushing’s Disease have scored a huge win after a vital medication was added to the Pharmaceutical Benefits Scheme.

From early warning signs to prevention tips, here’s all that you need to know about this rare hormonal disorder. Cushing’s syndrome refers to a hormonal disorder that occurs due to the ...

It is estimated up to 1600 Australians are living with Cushing’s Disease, with about 41 new cases of the disease diagnosed across the country each year. Osilodrostat (Isturisa), which has been ...